Qidni Labs
PrivateLast Round
Series A
Aug 12, 2025
Est. Valuation
$23M
Total Funding Raised
$8.68M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Qidni Labs operates in Healthcare & Life Sciences and is based in Buffalo, New York. Its latest recorded funding round was a Series A round in August 2025.
Qidni Labs is a medical device company that develops portable, nearly waterless hemodialysis systems designed to improve accessibility and sustainability for patients with kidney failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Water Treatment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qidni Labs Comparables
Compare Qidni Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nextkidney | 88% | |
| Physiologas Technologies Inc. | 87% | |
| US Kidney Research Corporation | 86% |
For institutional investors. Book with your work email.
Qidni Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 12, 2025 | ||||
| Grant | Jan 28, 2025 | ||||
| Seed | Jun 5, 2023 | ||||
| Grant | Jul 27, 2021 | ||||
| Grant | Apr 29, 2019 | ||||
Accelerator | Oct 6, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Qidni Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Ontario Bioscience Innovation Organization | Grant |
| IndieBio | Accelerator |
| 43North | Seed, Accelerator |
| Kidney Innovation Accelerator | Grant |
| SOSV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 12, 60% of headcount.
- Oct 12, 2026
Open roles increased to 7, representing 35% of headcount.
For institutional investors. Book with your work email.
Qidni Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qidni Labs's valuation, stock price, and market status.
Is Qidni Labs a public or private company?
Qidni Labs is a private company.
What is the current stock price of Qidni Labs?
Qidni Labs is a private company, so its shares have no public market price. Caplight tracks Qidni Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qidni Labs worth (valuation)?
Qidni Labs's valuation is estimated at $23.0M based on funding round data.
Can I buy Qidni Labs stock?
Qidni Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qidni Labs's last funding round?
Qidni Labs's most recent funding round was Series A on August 12, 2025.
Who are the main investors in Qidni Labs?
Key investors in Qidni Labs include Kidney Innovation Accelerator.
Will Qidni Labs IPO soon?
No public IPO plans have been announced for Qidni Labs.
How can I track Qidni Labs secondary market activity?
Caplight tracks bids, offers, and trades in Qidni Labs's shares on secondary markets.